Advances in Tumor Immunology and Immunotherapy

This volume explores recent advances in understanding of fundamental immunology  and insights into  the dynamic interactions between tumors and the immune system, that  provide new opportunities  for therapeutic  intervention in cancer.  Chapter topics include evolving paradigms in the innate and ad...

Full description

Bibliographic Details
Other Authors: Rosenblatt, Joseph D. (Editor), Podack, Eckhard R. (Editor), Barber, Glen N. (Editor), Ochoa, Augusto (Editor)
Format: eBook
Language:English
Published: New York, NY Springer New York 2014, 2014
Edition:1st ed. 2014
Series:Current Cancer Research
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01993nmm a2200313 u 4500
001 EB000420944
003 EBX01000000000000000274026
005 00000000000000.0
007 cr|||||||||||||||||||||
008 131104 ||| eng
020 |a 9781461488095 
100 1 |a Rosenblatt, Joseph D.  |e [editor] 
245 0 0 |a Advances in Tumor Immunology and Immunotherapy  |h Elektronische Ressource  |c edited by Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa 
250 |a 1st ed. 2014 
260 |a New York, NY  |b Springer New York  |c 2014, 2014 
300 |a IX, 371 p. 35 illus., 29 illus. in color  |b online resource 
653 |a Cancer research 
653 |a Pharmacology 
653 |a Cancer Research 
653 |a Pharmacology/Toxicology 
700 1 |a Podack, Eckhard R.  |e [editor] 
700 1 |a Barber, Glen N.  |e [editor] 
700 1 |a Ochoa, Augusto  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Current Cancer Research 
856 4 0 |u https://doi.org/10.1007/978-1-4614-8809-5?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 614.5999 
520 |a This volume explores recent advances in understanding of fundamental immunology  and insights into  the dynamic interactions between tumors and the immune system, that  provide new opportunities  for therapeutic  intervention in cancer.  Chapter topics include evolving paradigms in the innate and adaptive response,   newly appreciated immunosuppressive mechanisms,  and  novel preclinical  strategies for manipulation of the immune system for therapeutic benefit in cancer. In addition, recent successes in the clinic, and emerging opportunities are covered. Future possibilities, such as the use of antibody engineering, fusion proteins,  and the retargeting of immune cells through T-cell receptor engineering are discussed by  leaders in the field,  focusing  on recent clinical experience, promising technologies, and challenges to clinical success